According to a report from Mayo Clinic, most of the scientists who came out in support of GlaxoSmithKline diabetes drug Avandia were actually financially tied to the pharmaceutical company . The diabetes drug was linked to a far greater than average incidence of heart disease and death in a New England Journal of Medicine article .
The Mayo experts evaluated some 200 articles appearing after the initial diabetes news was published. They found that 90 per cent of the positive articles, commentaries and reviews were by experts with financial ties to Glaxo . The study was published in the British Medical Journal . Just 6 per cent of those who expressed positive opinions of the drug had no funding or fees from the industry .
The researchers were led by Amy Wang, a resident in internal medicine at the Mayo Clinic. She was reported as commenting: "We aimed to determine whether financial conflicts of interest with pharmaceutical manufacturers could be fuelling this fire. From our findings, it appears that the answer is yes. These findings, while not necessarily causal, underscore the need for further progress in reporting in order for the scientific record to be trusted."
Supporters of diabetes drug had financial ties to pharmaceutical company
Fri, 19 Mar 2010
Recommended links
Diabetes forumDiabetes myLifestyle
Diabetes donate
Diabetes signs and symptoms
Diabetes pensions and annuities
The Diet Plate for People with Diabetes
Diabetes.co.uk ID alert wristband
Supporters of diabetes drug had financial ties to pharmaceutical company
Diabetes injection Byetta LAR faces Food and Drug Administration decision
GlaxoSmithKline defends diabetes drug Avandia
Patient concern over diabetes drug Avandia
Food and Drug Administration say diabetes patients should not stop taking Avandia
Popular Cholesterol drugs increase diabetes risk
Smell of fish may put patients off diabetes drug
24 hour Diabetes drug Victoza approved for National Health Service use
Diabetes drug could cut body mass index
Weight loss drug alli could reduce dangerous diabetes fat
Type 2 diabetes drug gets Food and Drug Administration approval
Lexicon diabetes drug hits mid-stage trial
Diabetes drug clinical trials underway
Death risk increased 60 per cent by diabetes drug
Roche diabetes drug hits targets
New type 1 diabetes drug
Diabetes drug warning has doctors on alert
Label change for type 2 diabetes drug
Diabetes prevention using diet, not drugs
Diabetes drug better for weight loss
Diabetes drug may have pancreatitis risk
Denial over diabetes drug link
Heart risk not alleviated by diabetes drugs
Obesity increases diabetes drug bill
Med diet could delay diabetes drugs
Get forum updates, competition previews & diabetes community news.
